| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |